Spots Global Cancer Trial Database for Phase II Study of TKI258 in Advanced Urothelial Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase II Study of TKI258 in Advanced Urothelial Carcinoma
Official Title: A Phase II Multi-center, Non-randomized, Open Label Study of TKI258 in FGFR3 Mutated and FGFR3 Wild Type Advanced Urothelial Carcinoma
Study ID: NCT00790426
Conditions
Interventions
Study Description
Brief Summary: This study will evaluate the efficacy of TKI258 in patients with advanced urothelial cancer
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of California San Diego - Moores Cancer Center UCSD, La Jolla, California, United States
USC/Kenneth Norris Comprehensive Cancer Center Regulatory Contact 3, Los Angeles, California, United States
University Chicago Hospital CTKI258A2201, Chicago, Illinois, United States
Dana Farber Cancer Institute Dana 1230, Boston, Massachusetts, United States
Nevada Cancer Institute Nevada Cancer Institute, Las Vegas, Nevada, United States
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering (2), New York, New York, United States
Duke University Medical Center Dept.ofDukeUniversityMedCtr(2), Durham, North Carolina, United States
The West Clinic, Memphis, Tennessee, United States
Novartis Investigative Site, Vienna, , Austria
Novartis Investigative Site, Victoria, British Columbia, Canada
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Dresden, , Germany
Novartis Investigative Site, Ulm, , Germany
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Sevilla, Andalucia, Spain
Novartis Investigative Site, Barcelona, Catalunya, Spain
Novartis Investigative Site, Barcelona, Catalunya, Spain
Novartis Investigative Site, Barcelona, , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Tainan 704, Taiwan ROC, Taiwan
Novartis Investigative Site, Taipei, , Taiwan
Novartis Investigative Site, Leeds, West Yorkshire, United Kingdom
Novartis Investigative Site, Southampton, , United Kingdom
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
